Ahammune Biosciences, an innovative biotech firm focused on dermatological therapies, has successfully raised $5 million in a Series A funding round led by the early-stage venture capital firm pi Ventures. This funding round also welcomed participation from Capital2B, Colossa Ventures, Bipin Agarwal, Unicornus Maximus LLP, along with existing investors such as Ideaspring Capital, Kotak Alternate…
